In conclusion, upregulation of clusterin in the fibrotic liver can be a protective response whatever the cause of fibrosis, and clusterin reduces hepatic fibrosis by inhibiting HSC activation and Smad3 signaling pathways. The gene discussed is SMAD3; the disease is fibrosis.